Skip to main content
Northwestern University Feinberg School of Medicine
Mesulam Center for Cognitive Neurology and Alzheimer’s Disease
Skip to main content

Study Details

Advancing Research and Treatment for Frontotemporal Lobar Degeneration
Frontotemporal Lobar Degeneration (FTLD) is the neuropathological term for a collection of rare neurodegenerative diseases that correspond to four main overlapping clinical syndromes: frontotemporal dementia (FTD), primary progressive aphasia (PPA), corticobasal degeneration syndrome (CBS) and progressive supranuclear palsy syndrome (PSPS). The goal of this study is to build a FTLD clinical research consortium to support the development of FTLD therapies for new clinical trials. This study is observational and requires a one-time visit, referred to as the Baseline visit. All ARTFL participants will co-enroll into the Alzheimer's Disease Core Center study. 
1. Between 18 and 85 (inclusive) years of age.2. Able to walk (with assistance) at the time of enrollment.3. Have a reliable study partner who can provide an independent evaluation of functioning.4. Speak fluent English.5. Ability to sit for 4-5 hours to undergo cognitive testing, questionnaires, interviews, and a neurological exam.6. Meet the clinical diagnostic criteria for PSP, semantic PPA, CBS, bvFTD, FTD-ALS, or non-fluent PPA.
Weintraub, SandraWeintraub, Sandra
NCT02365922 STU00200202
More Info

For more information on this study please contact us:

Study Coordinator 312 503 5103
Back to top

Follow Mesulam Center on